Dr. Jyoti Nangalia of the Wellcome Sanger Institute and Cambridge Stem Cell Institute provides an overview of
what patients can expect when living with a
myeloproliferative neoplasm (
MPN). She explains that for many people, especially those with low-risk disease, MPNs can often be managed with
regular monitoring and healthy
lifestyle choices. For those needing more active treatment, care may include
medication adjustments,
follow-up tests, or additional procedures such as
bone marrow biopsies. Dr. Nangalia emphasizes the importance of minimizing cardiovascular risk factors, staying engaged with healthcare providers, and tailoring care based on individual risk, symptoms, and disease progression.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about myeloproliferative neoplasms which will help other patients, caregivers, and families.